These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

125 related items for PubMed ID: 8083102

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Radiation Therapy Oncology Group (RTOG) 88-08 and Eastern Cooperative Oncology Group (ECOG) 4588: preliminary results of a phase III trial in regionally advanced, unresectable non-small-cell lung cancer.
    Sause WT, Scott C, Taylor S, Johnson D, Livingston R, Komaki R, Emami B, Curran WJ, Byhardt RW, Turrisi AT.
    J Natl Cancer Inst; 1995 Feb 01; 87(3):198-205. PubMed ID: 7707407
    [Abstract] [Full Text] [Related]

  • 26. Docetaxel plus nintedanib versus docetaxel plus placebo in patients with previously treated non-small-cell lung cancer (LUME-Lung 1): a phase 3, double-blind, randomised controlled trial.
    Reck M, Kaiser R, Mellemgaard A, Douillard JY, Orlov S, Krzakowski M, von Pawel J, Gottfried M, Bondarenko I, Liao M, Gann CN, Barrueco J, Gaschler-Markefski B, Novello S, LUME-Lung 1 Study Group.
    Lancet Oncol; 2014 Feb 01; 15(2):143-55. PubMed ID: 24411639
    [Abstract] [Full Text] [Related]

  • 27. Prospective study of epidermal growth factor receptor tyrosine kinase inhibitors concurrent with individualized radiotherapy for patients with locally advanced or metastatic non-small-cell lung cancer.
    Wang J, Xia TY, Wang YJ, Li HQ, Li P, Wang JD, Chang DS, Liu LY, Di YP, Wang X, Wu WZ.
    Int J Radiat Oncol Biol Phys; 2011 Nov 01; 81(3):e59-65. PubMed ID: 21345607
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. A randomized trial of induction chemotherapy plus high-dose radiation versus radiation alone in stage III non-small-cell lung cancer.
    Dillman RO, Seagren SL, Propert KJ, Guerra J, Eaton WL, Perry MC, Carey RW, Frei EF, Green MR.
    N Engl J Med; 1990 Oct 04; 323(14):940-5. PubMed ID: 2169587
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Thoracic irradiation with or without levamisole (NSC #177023) in unresectable non-small cell carcinoma of the lung: a phase III randomized trial of the RTOG.
    Perez CA, Bauer M, Emami BN, Byhardt R, Brady LW, Doggett RL, Gardner P, Zinninger M.
    Int J Radiat Oncol Biol Phys; 1988 Dec 04; 15(6):1337-46. PubMed ID: 2848786
    [Abstract] [Full Text] [Related]

  • 32. Recombinant human interferon-beta (rHuIFN-beta) and radiation therapy for inoperable non-small cell lung cancer.
    Byhardt RW, Vaickus L, Witt PL, Chang AY, McAuliffe T, Wilson JF, Lawton CA, Breitmeyer J, Alger ME, Borden EC.
    J Interferon Cytokine Res; 1996 Nov 04; 16(11):891-902. PubMed ID: 8938564
    [Abstract] [Full Text] [Related]

  • 33. Concurrent daily carboplatin and accelerated hyperfractionated thoracic radiotherapy in locally advanced nonsmall cell lung cancer.
    Kunitoh H, Watanabe K, Nagatomo A, Okamoto H, Kimbara K.
    Int J Radiat Oncol Biol Phys; 1997 Jan 01; 37(1):103-9. PubMed ID: 9054883
    [Abstract] [Full Text] [Related]

  • 34. Misonidazole combined with radiotherapy in the treatment of non-small cell lung cancer. A randomized double-blind trial.
    Jakobsson M, Taskinen PJ, Kylmämaa T.
    Strahlenther Onkol; 1987 Feb 01; 163(2):90-3. PubMed ID: 3031840
    [Abstract] [Full Text] [Related]

  • 35. Outcomes of patients with stage III nonsmall cell lung cancer treated with chemotherapy and radiation with and without surgery.
    Caglar HB, Baldini EH, Othus M, Rabin MS, Bueno R, Sugarbaker DJ, Mentzer SJ, Jänne PA, Johnson BE, Allen AM.
    Cancer; 2009 Sep 15; 115(18):4156-66. PubMed ID: 19551884
    [Abstract] [Full Text] [Related]

  • 36. Twice-weekly paclitaxel and radiation for stage III non-small cell lung cancer.
    Lau DH, Ryu JK, Gandara DR, Morgan R, Doroshow J, Wilder R, Leigh B.
    Semin Oncol; 1997 Aug 15; 24(4 Suppl 12):S12-106-S12-109. PubMed ID: 9331132
    [Abstract] [Full Text] [Related]

  • 37. Randomized phase II chemotherapy and radiotherapy trial for patients with locally advanced inoperable non-small-cell lung cancer: long-term follow-up of RTOG 92-04.
    Komaki R, Seiferheld W, Ettinger D, Lee JS, Movsas B, Sause W.
    Int J Radiat Oncol Biol Phys; 2002 Jul 01; 53(3):548-57. PubMed ID: 12062596
    [Abstract] [Full Text] [Related]

  • 38. Lonidamine versus high-dose tamoxifen in progressive, advanced renal cell carcinoma: results of an ongoing randomized phase II study.
    Stahl M, Schmoll E, Becker H, Schlichter A, Hoffmann L, Wagner H, Possinger K, Müller W, Köllermann M, Weidenhammer W.
    Semin Oncol; 1991 Apr 01; 18(2 Suppl 4):33-7. PubMed ID: 2031196
    [Abstract] [Full Text] [Related]

  • 39. Phase II study of lonidamine in non-small cell lung cancer: final report.
    Kokron O, Maca S, De Gregorio M, Ciottoli GB.
    Br J Cancer; 1990 Feb 01; 61(2):316-8. PubMed ID: 2155644
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.